~~<i id='362E134474'><strike id='362E134474'><tt id='362E134474'><pre id='362E134474'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

fashion

author：knowledge 2025-09-29 21:20:49 - browse：9871

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Statins reduce cardiovascular risk in people living with HIV

focus

knowledge

leisure time

entertainment

focus

explore

CRISPRpioneersJenniferDoudnaandFengZhangIllustration:STAT;Photos:AP,GettyTherevolutionstartedinsilen

WSS

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Doctors have an ethical obligation to be advocates

FAMU bans football players from facility after release of rap video shot in team's locker room

FAMU bans football players from facility after release of rap video shot in team's locker room

knowledge

fashion

focus

Sports medicine is finally prioritizing gender equality

Novartis develops a rapidly manufactured CAR

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Astellas still sees hope in its gene therapy after four deaths

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A daunting task: navigating dual Medicare, Medicaid eligibility

Psychedelics group wrestles with new pharma identity

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Medical leaders decry Supreme Court decision on affirmative action

U.K. considers world's first use of meningitis vaccine to address gonorrhea

knowledge

FAMU bans football players from facility after release of rap video shot in team's locker room

PBM reforms clear House panel

Surge of respiratory disease in China has likely explanation

4 missing after record

Severe heat forecast: Where scorching temperatures will persist over the next week

FAMU bans football players from facility after release of rap video shot in team's locker room

leisure time

entertainment

focus

explore